- Home
- CMPS vs DDD Comparison
CMPS vs DDD Comparison
Compare CMPS & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- DDD
- Stock Information
- Founded
- CMPS 2020
- DDD 1986
- Country
- CMPS United Kingdom
- DDD United States
- Employees
- CMPS N/A
- DDD N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- DDD Computer peripheral equipment
- Sector
- CMPS Health Care
- DDD Technology
- Exchange
- CMPS Nasdaq
- DDD Nasdaq
- Market Cap
- CMPS 246.5M
- DDD 248.4M
- IPO Year
- CMPS 2020
- DDD N/A
- Fundamental
- Price
- CMPS $3.51
- DDD $1.85
- Analyst Decision
- CMPS Strong Buy
- DDD Hold
- Analyst Count
- CMPS 6
- DDD 3
- Target Price
- CMPS $20.20
- DDD $3.50
- AVG Volume (30 Days)
- CMPS 836.8K
- DDD 3.1M
- Earning Date
- CMPS 05-07-2025
- DDD 03-26-2025
- Dividend Yield
- CMPS N/A
- DDD N/A
- EPS Growth
- CMPS N/A
- DDD N/A
- EPS
- CMPS N/A
- DDD N/A
- Revenue
- CMPS N/A
- DDD $440,121,000.00
- Revenue This Year
- CMPS N/A
- DDD N/A
- Revenue Next Year
- CMPS N/A
- DDD $5.15
- P/E Ratio
- CMPS N/A
- DDD N/A
- Revenue Growth
- CMPS N/A
- DDD N/A
- 52 Week Low
- CMPS $2.49
- DDD $1.72
- 52 Week High
- CMPS $9.63
- DDD $5.00
- Technical
- Relative Strength Index (RSI)
- CMPS 60.07
- DDD 31.41
- Support Level
- CMPS $2.94
- DDD $1.71
- Resistance Level
- CMPS $3.11
- DDD $2.13
- Average True Range (ATR)
- CMPS 0.22
- DDD 0.15
- MACD
- CMPS 0.11
- DDD 0.02
- Stochastic Oscillator
- CMPS 93.57
- DDD 28.40
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.